Ceribell to Report Third Quarter 2026 Financial Results on November 3, 2026
Key Highlights
- ➤Ceribell (CBLL) will release third-quarter 2026 financial results November 3, 2026
- ➤Management will host a results conference call at 1:30 p.m. PT
- ➤Ceribell's FDA-cleared System supports seizure assessment and critical-care delirium monitoring
SUNNYVALE, Calif., Oct. 20, 2026 (GLOBE NEWSWIRE) -- CeriBell, Inc. (Nasdaq: CBLL) (“Ceribell”), a medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions, today announced that it will release financial results for the third quarter of 2026 after the close of trading on Tuesday, November 3, 2026. Company management will host a conference call to discuss financial results beginning at 1:30 p.m. PT / 4:30 p.m. ET on November 3, 2026.
Investors interested in listening to the conference call may do so by dialing (800) 715-9871 for domestic callers or (646) 307-1963 for international callers and providing access code 1880547. A live and archived webcast of the event will be available in the "Investor Relations" section of the Ceribell website at https://investors.ceribell.com/.
Get started
Create a free account to read the full story.